PM
AVTX icon

Prosight Management’s Avalo Therapeutics AVTX Stock Holding History

Prosight Management’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40
Closed -$665K – 39
2019
Q1 		$665K Sell
40
-67
-63% -$1.11M 0.29% 32
2018
Q4 		$994K Buy
+107
New +$994K 0.51% 31